Vera Therapeutics Inc [VERA] stock prices are down -1.18% to $49.21 at the moment. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The VERA shares have gain 9.28% over the last week, with a monthly amount glided 73.46%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Vera Therapeutics Inc [NASDAQ: VERA] stock has seen the most recent analyst activity on October 16, 2025, when BofA Securities initiated its Buy rating and assigned the stock a price target of $48. Previously, Wolfe Research downgraded its rating to Peer Perform on August 04, 2025. Wolfe Research started tracking the stock assigning an Outperform rating and suggested a price target of $49 on February 04, 2025. Goldman initiated its recommendation with a Buy and recommended $58 as its price target on January 28, 2025. Wells Fargo started tracking with an Overweight rating for this stock on November 21, 2024, and assigned it a price target of $70. In a note dated October 16, 2024, Scotiabank initiated an Sector Outperform rating.
The stock price of Vera Therapeutics Inc [VERA] has been fluctuating between $18.53 and $50.16 over the past year. Currently, Wall Street analysts expect the stock to reach $73.25 within the next 12 months. Vera Therapeutics Inc [NASDAQ: VERA] shares were valued at $49.21 at the most recent close of the market. An investor can expect a potential return of 48.85% based on the average VERA price forecast.
Analyzing the VERA fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.38, Equity is -0.47 and Total Capital is -0.43. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.17.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 48.21 points at the first support level, and at 47.21 for the second support level. However, for the 1st resistance point, the stock is sitting at 50.70, and for the 2nd resistance point, it is at 52.19.
Ratios To Look Out For
It’s worth pointing out that Vera Therapeutics Inc [NASDAQ:VERA]’s Current Ratio is 12.09. As well, the Quick Ratio is 12.09, while the Cash Ratio is 1.46.
Transactions by insiders
Recent insider trading involved ENRIGHT PATRICK G, Director, that happened on Dec 11 ’25 when 5882.0 shares were purchased. Officer, WILLIAM TURNER completed a deal on Dec 15 ’25 to buy 10000.0 shares. Meanwhile, Chief Regulatory Officer Turner William D. sold 10000.0 shares on Dec 08 ’25.
